Rank 77 • Consumer & Prevention
Ezra
Offers AI-powered full-body MRI screening scans designed to detect early-stage cancer and other abnormalities.
Visit website- Signal Score
- 83.8
- Total raised
- $41M
- Stage
- Series B
- Founded
- 2018
- Headquarters
- New York, United States
- Region
- North America
Their signal
Ezra leads the direct-to-consumer medical imaging market, using proprietary AI to decrease MRI scan times and reduce consumer price points.
Signal Score 83.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Consumer & Prevention
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.